Meta-Analysis and Cost Comparison of Empirical versus Pre-Emptive Antifungal Strategies in Hematologic Malignancy Patients with High-Risk Febrile Neutropenia

Combination Antifungal Therapy for Invasive Aspergillosis

(2015) Kieren A. Marr et al.   ANNALS OF INTERNAL MEDICINE

Economic Comparison of an Empirical Versus Diagnostic-Driven Strategy for Treating Invasive Fungal Disease in Immunocompromised Patients

(2015) Rosemary Barnes et al.   CLINICAL THERAPEUTICS

Serum Galactomannan Versus a Combination of Galactomannan and Polymerase Chain Reaction-Based Aspergillus DNA Detection for Early Therapy of Invasive Aspergillosis in High-Risk Hematological Patients: A Randomized Controlled Trial

(2014) J. M. Aguado et al.   CLINICAL INFECTIOUS DISEASES

Cost-Effectiveness Analysis Comparing Two Approaches for Empirical Antifungal Therapy in Hematological Patients with Persistent Febrile Neutropenia

(2013) Almudena Martín-Peña et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical and economic burden of invasive fungal diseases in Europe: focus on pre-emptive and empirical treatment of Aspergillus and Candida species

(2013) L. Drgona et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

The end of the road for empirical antifungal treatment?

(2013) J Peter Donnelly et al.   LANCET INFECTIOUS DISEASES

Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial

(2013) C Orla Morrissey et al.   LANCET INFECTIOUS DISEASES

 -Glucan Antigenemia Assay for the Diagnosis of Invasive Fungal Infections in Patients With Hematological Malignancies: A Systematic Review and Meta-Analysis of Cohort Studies From the Third European Conference on Infections in Leukemia (ECIL-3)

(2011) F. Lamoth et al.   CLINICAL INFECTIOUS DISEASES

Executive Summary: Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America

(2011) Alison G. Freifeld et al.   CLINICAL INFECTIOUS DISEASES

The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project

(2011) L. Pagano et al.   HAEMATOLOGICA

Galactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study

(2011) Ban Hock Tan et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT

(2010) O Blennow et al.   BONE MARROW TRANSPLANTATION

Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001–2006: Overview of the Transplant‐Associated Infection Surveillance Network (TRANSNET) Database

(2010) Dimitrios P. Kontoyiannis et al.   CLINICAL INFECTIOUS DISEASES

Systematic review and mixed treatment comparison of randomized evidence for empirical, pre-emptive and directed treatment strategies for invasive mould disease

(2010) N. Freemantle et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Critical Stages of Extracting DNA from Aspergillus fumigatus in Whole-Blood Specimens

(2010) P. L. White et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Empirical antifungal therapy in selected patients with persistent febrile neutropenia

(2009) M Aguilar-Guisado et al.   BONE MARROW TRANSPLANTATION

Empirical versus Preemptive Antifungal Therapy for High‐Risk, Febrile, Neutropenic Patients: A Randomized, Controlled Trial

(2009) Catherine Cordonnier et al.   CLINICAL INFECTIOUS DISEASES

Diagnostic Performance of the (1→3)‐β‐d‐Glucan Assay for Invasive Fungal Disease

(2009) Sophia Koo et al.   CLINICAL INFECTIOUS DISEASES

Clinically Driven Diagnostic Antifungal Approach in Neutropenic Patients: A Prospective Feasibility Study

(2009) Corrado Girmenia et al.   JOURNAL OF CLINICAL ONCOLOGY

Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis

(2009) Carlo Mengoli et al.   LANCET INFECTIOUS DISEASES

Aspergillosis

(2009) Brahm H. Segal   NEW ENGLAND JOURNAL OF MEDICINE

A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after allo-SCT

(2008) H Hebart et al.   BONE MARROW TRANSPLANTATION

 -D-Glucan Detection Test: A Step Toward Preemptive Therapy for Fungal Infections in Leukemic Patients?

(2008) R. Herbrecht et al.   CLINICAL INFECTIOUS DISEASES

Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America

(2008) Thomas J. Walsh et al.   CLINICAL INFECTIOUS DISEASES

Outcome and Medical Costs of Patients with Invasive Aspergillosis and Acute Myelogenous Leukemia–Myelodysplastic Syndrome Treated with Intensive Chemotherapy: An Observational Study

(2008) Lennert Slobbe et al.   CLINICAL INFECTIOUS DISEASES

Factors Associated with Overall and Attributable Mortality in Invasive Aspergillosis

(2008) Yasmine Nivoix et al.   CLINICAL INFECTIOUS DISEASES

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

(2008) Ben De Pauw et al.   CLINICAL INFECTIOUS DISEASES